A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects with Critical Limb Ischemia
|Effective start/end date||7/1/10 → 6/30/14|
- ViroMed Co., Ltd.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.